Skip to search formSkip to main contentSkip to account menu

VP 16-213

Known as: VP 16213, VP-16-213, VP 16 213 
National Institutes of Health

Related topics

Related topics

3 relations
EpipodophyllotoxinVepesid

Broader (1)

Etoposide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
One hundred ninety patients with germ cell line testicular tumours were treated according to the modified Einhorn scheme. The… 
Review
1991
Review
1991
Optimal Drug Therapy in the Treatment of Testicular Cancer
SummaryAlthough testes cancer is the most common malignancy affecting young men, dramatic survival rates are now possible with… 
1989
1989
Third-line chemotherapy of resistant advanced testicular cancer.
The efficacy of combined chemotherapy of Vepesid + Holoxan +/- Adriblastin as third-choice was studied in advanced testicular… 
1988
1988
Ifosfamide and VP-16213 combination chemotherapy combined with ablative chemotherapy and autologous marrow transplantation as salvage treatment for malignant lymphoma.
1984
1984
In vitro cytotoxicity of VP-16213 on human ovarian cancer.
1982
1982
Evaluation of 2 treatment schedules of the combination of VP-16213 (VP16) and platinum (CDDP) for patients (PTS) with advanced adeno and squamous cell lung cancer (ASCLC)
1976
1976
Antimetastasis effect of two derivatives of epiposophyllotoxin in mice.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)